Cargando…
Efficacy and safety of interferon on neonates with respiratory syncytial virus pneumonia
Respiratory syncytial virus (RSV) pneumonia is a leading cause of hospitalization and mortality among neonates worldwide, and there are currently no specific clinical treatments for RSV infection. Interferons (IFNs) possess broad-spectrum antiviral properties, and the present study aimed to evaluate...
Autores principales: | He, Lingyun, Yang, Lu, Zhang, Hua, Luo, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646691/ https://www.ncbi.nlm.nih.gov/pubmed/33193835 http://dx.doi.org/10.3892/etm.2020.9350 |
Ejemplares similares
-
Recurrent wheezing in neonatal pneumonia is associated with combined infection with Respiratory Syncytial Virus and Staphylococcus aureus or Klebsiella pneumoniae
por: Zhong, Qin, et al.
Publicado: (2018) -
The efficacy of intranasal interferonα-2a in respiratory syncytial virus infection in volunteers
por: Higgins, P.G., et al.
Publicado: (1990) -
Role of Respiratory Syncytial Virus in Pediatric Pneumonia
por: Bianchini, Sonia, et al.
Publicado: (2020) -
Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf
por: McGill, Jodi L., et al.
Publicado: (2018) -
Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013)